tizanidine has been researched along with Takotsubo Cardiomyopathy in 1 studies
tizanidine: RN given refers to parent cpd; structure
tizanidine : 2,1,3-Benzothiadiazole substituted at C-4 by a Delta(1)-imidazolin-2-ylamino group and at C-4 by a chloro group. It is an agonist at alpha2-adrenergic receptor sites.
Takotsubo Cardiomyopathy: A transient left ventricular apical dysfunction or ballooning accompanied by electrocardiographic (ECG) T wave inversions. This abnormality is associated with high levels of CATECHOLAMINES, either administered or endogenously secreted from a tumor or during extreme stress.
Excerpt | Relevance | Reference |
---|---|---|
" The drug should be gradually reduced in dosage under observation by a psychiatrist." | 1.42 | [Tizanidine withdrawal symptoms in stress cardiomyopathy]. ( Bayer, D; Bengesser, SA; Kapfhammer, HP; Mörkl, S; Schöggl, H, 2015) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mörkl, S | 1 |
Bengesser, SA | 1 |
Schöggl, H | 1 |
Bayer, D | 1 |
Kapfhammer, HP | 1 |
1 other study available for tizanidine and Takotsubo Cardiomyopathy
Article | Year |
---|---|
[Tizanidine withdrawal symptoms in stress cardiomyopathy].
Topics: Adrenergic alpha-2 Receptor Agonists; Clonidine; Electrocardiography; Humans; Male; Middle Aged; Mus | 2015 |